Abstract：Objective: To explore the relationship between long-chain non-coding RNA plasmacytoma ectopic variant gene 1 (LncRNA PVT1), adenosine triphosphate binding transporter G2 (ABCG2) mRNA expression and pathological characteristics in breast cancer tissues, and analysis of KM curve. Methods: The case data of 80 breast cancer patients who underwent surgical treatment in our hospital between January 2017 and July 2018 were selected for retrospective study.During the operation, breast cancer tissues and adjacent tissues (2cm from the lesion) were collected to compare the expression of LncRNA PVT1 and ABCG2 mRNA in the cancer tissues and adjacent tissues.The correlation between LncRNA PVT1, ABCG2 mRNA expression and pathological characteristics in cancer tissues were analyzed.The expression of LncRNA PVT1 and ABCG2 mRNA in cancer tissues of patients with and without recurrence were compared.COX regression was used to analyze the correlation between LncRNA PVT1 and ABCG2 mRNA expressions and recurrence in cancer tissues.The disease-free survival of patients with LncRNA PVT1 and ABCG2 mRNA expression in different cancer tissues was compared. Results: The expression of LncRNA PVT1 (0.076±0.011) and ABCG2 mRNA (3.27±0.45) in cancer tissues was higher than that in adjacent tissues (0.003±0.001),(0.82±0.26)(t=59.114,42.165,P<0.05); the expression of LncRNA PVT1 and ABCG2 mRNA in cancer tissues was related to clinical stage, pathological grade, and lymph node metastasis (P<0.05); the expression of LncRNA PVT1 (0.084±0.010) and ABCG2 mRNA (3.75±0.59) in cancer tissues of relapsed patients was higher than that of non-relapsed patients (0.074±0.009),(3.13±0.47)(t=4.048,4.644,P<0.05); COX regression analysis showed that the high expression of LncRNA PVT1 and ABCG2 mRNA in cancer tissues were independent risk factors for postoperative recurrence (P<0.05); Kaplan-Meier survival analysis showed that patients with high expression of LncRNA PVT1 and ABCG2 mRNA in cancer tissues had a lower 3-year disease-free survival rate than those with low expression (P<0.05). Conclusion: The abnormally high expression of LncRNA PVT1 and ABCG2 mRNA in the cancer tissues of breast cancer patients is associated with pathological characteristics and disease-free survival, and is expected to become a new therapeutic target.
徐亮, 王杜娟, 谢倩, 李松梅, 黄述斌. 乳腺癌组织LncRNA PVT1 ABCG2 mRNA表达与病理特征间关系及KM曲线分析[J]. 河北医学, 2022, 28(9): 1457-1461.
XU Liang, et al. Relationship between LncRNA PVT1 and ABCG2 mRNA Expression and Pathological Characteristics in Breast Cancer Tissues and Analysis of KM Curve. HeBei Med, 2022, 28(9): 1457-1461.
[1] Naik A,Al-Yahyaee A,Abdullah N,et al.Neuropilin-1 promotes the oncogenic tenascin-C/ integrin β3 pathway and modulates chemoresistance in breast cancer cells[J].Bmc Cancer,2018,18(1):533. [2] 王月波,蒲红.乳腺癌增强MRI形态学特征及表观扩散系数值与相关分子生物学标记物的关系分析[J].实用放射学杂志,2020,36(2):219-222. [3] 张硕,沈泳,高秀飞,等.双荧光素酶报告法验证乳腺癌中IncRNA PVT1为let-7c-5p的靶基因[J].浙江医学,2020,42(1):11-15. [4] Chang FW,Fan HC,Liu JM,et al.Estrogen enhances the expression of the multidrug transporter gene ABCG2-increasing drug resistance of breast cancer cells through estrogen receptors[J].Int Mol Sci,2017,18(1):163. [5] 高德军,李建亮,张世英.长链非编码RNA浆细胞瘤变异易位1靶向微RNA-140-5p调控肺癌细胞增殖凋亡及自噬的分子机制[J].中华生物医学工程杂志,2019,25(1):75-80. [6] 李幸,魏雪晴,王丽,等.LncRNA PVT1及PD-L1表达与顺铂耐药上皮性卵巢癌临床病理特征及预后的相关性分析[J].中国肿瘤临床,2021,48(2):60-65. [7] 李晓珍,任琛琛,刘灵,等.浆细胞瘤多样异位基因1在卵巢癌组织中的表达及其对SKOV3细胞恶性生物学行为的影响[J].中国肿瘤生物治疗杂志,2018,25(2):153-157. [8] Nickel S,Selo MA,Fallack J,et al.Expression and activity of breast cancer resistance protein (BCRP/ABCG2) in human distal lung epithelial cells in vitro[J].Pharm Res,2017,34(12):2477-2487. [9] 张春雷,王猛,吴洁,等.长链非编码RNA H19调控激素依赖型乳腺癌干细胞自我更新的作用及机制研究[J].现代肿瘤医学,2020,28(3):364-369. [10] 郑淑君.乳腺癌中ABCG2、P-gp与淋巴细胞亚群的相关研究[D].承德医学院,2012. [11] 刘国新,王伟伟,麦潋曦,等.顺铂诱导舌鳞癌细胞发生上皮-间充质转化及获得肿瘤干细胞样特性的实验研究[J].中国口腔颌面外科杂志,2020,18(1):10-16.
2022, Vol. 28 
冀公网安备13080202000677号